Breakthrough trichosporonosis in patients with acute myeloid leukemia receiving micafungin

被引:18
作者
Akagi, Tomoaki
Yamaguti, Kohei
Kawamura, Tizuko
Nakumura, Toshihiko
Kubo, Komei
Takemori, Hiromitu
机构
[1] Aomori Prefectural Hosp, Dept Rheumatol & Hematol, Aomori 0308553, Japan
[2] Aomori Prefectural Hosp, Dept Pathol & Clin Labs, Aomori 0308553, Japan
关键词
D O I
10.1080/10428190500272499
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
[No abstract available]
引用
收藏
页码:1182 / 1183
页数:2
相关论文
共 12 条
[1]   Comparison of in vitro activities of the new triazole SCH56592 and the echinocandins MK-0991 (L-743,872) and LY303366 against opportunistic filamentous and dimorphic fungi and yeasts [J].
Espinel-Ingroff, A .
JOURNAL OF CLINICAL MICROBIOLOGY, 1998, 36 (10) :2950-2956
[2]   Use of voriconazole to successfully treat disseminated Trichosporon asahii infection in a patient with acute myeloid leukaemia [J].
Fournier, S ;
Pavageau, W ;
Feuillhade, M ;
Deplus, S ;
Zagdanski, AM ;
Verola, O ;
Dombret, H ;
Molina, JM .
EUROPEAN JOURNAL OF CLINICAL MICROBIOLOGY & INFECTIOUS DISEASES, 2002, 21 (12) :892-896
[3]  
GOLD JWM, 1981, CANCER, V48, P2163, DOI 10.1002/1097-0142(19811115)48:10&lt
[4]  
2163::AID-CNCR2820481008&gt
[5]  
3.0.CO
[6]  
2-T
[7]  
HOY J, 1986, REV INFECT DIS, V8, P959
[8]  
MARTINO P, 1990, REV INFECT DIS, V12, P570
[9]   In vitro activities of a new lipopeptide antifungal agent, FK463, against a variety of clinically important fungi [J].
Tawara, S ;
Ikeda, F ;
Maki, K ;
Morishita, Y ;
Otomo, K ;
Teratani, N ;
Goto, T ;
Tomishima, M ;
Ohki, H ;
Yamada, A ;
Kawabata, K ;
Takasugi, H ;
Sakane, K ;
Tanaka, H ;
Matsumo, F ;
Kuwahara, S .
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2000, 44 (01) :57-62
[10]   In vitro activity of a new echinocandin, LY303366, compared with those of amphotericin B and fluconazole against clinical yeast isolates [J].
Uzun, O ;
Kocagoz, S ;
Cetinkaya, Y ;
Arikan, S ;
Unal, S .
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 1997, 41 (05) :1156-1157